Slim Weight Loss Clinic（Chicago, IL）
常见问题
How long before Semaglutide starts to work?
Patients who use Semaglutide for weight loss typically begin seeing results after the first four weeks of treatment.
Is Semaglutide approved for weight loss?
Yes, Semaglutide is FDA approved as a safe and effective treatment for weight management and obesity.
What is the difference between Saxenda and Semaglutide?
Although both Saxenda (Liraglutide) and Semaglutide are GLP-1 agonists that mimic the glucagon-like peptide, Semaglutide is more effective at improving blood glucose levels and achieving weight loss than Saxenda.
What if I miss a dose?
If you miss administering a dose of Semaglutide, you should take it as soon as you remember.
Can the drug improve overall health?
Yes. By improving weight loss, Semaglutide can also help improve cardiovascular, physical, and mental health.
How long does it take to lose weight on Semaglutide?
That will depend on your body type and the level of treatment.
诊所简介
Slim Weight Loss Clinic in Chicago, IL offers Semaglutide, Tirzepatide & Liraglutide peptide therapy under Dr. Gary Marshall, MD, FACS for medical weight loss.
Slim Weight Loss Clinic in Chicago, IL operates under the medical direction of Dr. Gary T. Marshall, MD, FACS, a board-certified surgeon who applies surgical precision to non-surgical weight management protocols. The clinic focuses exclusively on medically supervised weight loss using FDA-approved GLP-1 receptor agonist peptides, providing an alternative pathway for patients seeking significant weight reduction without bariatric surgery. Dr. Marshall’s dual expertise in surgical and medical weight management informs treatment protocols that address obesity as a chronic metabolic condition requiring ongoing clinical intervention rather than short-term dieting approaches.
Slim Weight Loss Clinic’s peptide therapy menu includes Liraglutide, Semaglutide, and Tirzepatide, with treatment protocols customized based on individual health goals and lab work. Additional peptide options may be available based on medical necessity and FDA guidelines.
Dr. Marshall conducts initial consultations that include metabolic panel analysis, body composition assessment, cardiovascular screening, and evaluation of obesity-related comorbidities including type 2 diabetes, hypertension, and sleep apnea. His fellowship training in advanced surgical techniques informs his understanding of adipose tissue physiology and metabolic dysfunction, allowing him to identify patients who will benefit most from peptide intervention versus those requiring alternative approaches. The clinic maintains collaborative relationships with endocrinologists and cardiologists throughout Chicago for patients with complex metabolic conditions requiring multidisciplinary management alongside peptide therapy.
Patients attend in-person appointments at the Chicago clinic location for medication initiation, dose adjustments, and ongoing monitoring throughout treatment. Follow-up visits typically occur every 2-4 weeks during dose escalation phases, then monthly once maintenance dosing is established. Each visit includes weight tracking, side effect assessment, nutritional counseling, and metabolic marker review to ensure safe progression toward weight loss targets. The clinic provides injection technique training for patients self-administering weekly subcutaneous peptides, along with detailed guidance on managing common effects such as nausea, constipation, and appetite changes that accompany GLP-1 therapy.
Slim Weight Loss Clinic differentiates itself through Dr. Marshall’s surgical background, which provides patients access to a physician who understands both medical and surgical weight loss pathways and can guide decisions about treatment escalation if peptide therapy proves insufficient. The clinic does not offer telehealth services, requiring all patients to establish care through in-person evaluation in Chicago, which allows for thorough physical examination and direct assessment of factors that influence peptide therapy success. This hands-on approach ensures appropriate patient selection for these powerful metabolic medications and enables rapid intervention if complications arise during treatment.